The multi-year agreement will give Novartis access to AbCellera's expertise and state-of-the-art antibody discovery technology for up to ten clinically-relevant disease targets. / read more /
The companies will jointly develop and commercialize an investigational bifunctional fusion protein immunotherapy currently in clinical development for cancer treatment. / read more /
GS1, a global supply-chain standards organization, launched a new messaging standard in collaboration with GS1 US to help meet the requirements of the US Drug Supply Chain Security Act (DSCSA) for salable returns of serialized prescription drugs. / read more /
The strategic partnership is expected to bring a new source of supply to providers, alleviating in particular the two-year shortage of metoprolol injection. / read more /
Big data technology company, Aigenpulse, has been granted with International Organization for Standardization (ISO) 9001:2015 and ISO 27001:2013 certification. / read more /
C-Bridge Capital will form a new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis to accelerate clinical development and registration of Samsung Bioepis' next-generation biosimilars in China. / read more /
Pathios Therapeutics and Sygnature Discovery have signed a strategic and innovative partnership agreement aimed at accelerating Pathios' drug discovery and development programs. / read more /
In a partnership with Thermo Fisher Scientific Pharma Services, Pacira added a manufacturing suite in Swindon, UK, that doubles the company's capacity by mirroring the company's facility in San Diego, CA. / read more /
The companies will develop a software-connected pipetting system for improved reproducibility and traceability in life-science laboratories. / read more /
Spectroscopic-based control methods were introduced as equivalent alternative methods, first to a gas chromatographic method to monitor an in-process solvent exchange step and second to a potentiometric titration method to release a process input material for drug substance manufacturing. / read more /
Using a QbD approach in the development and formulation of topical products will enable the drug developer to provide a robust control strategy for manufacturing. / read more /
Radha Iyer, vice-president and head of Quality and Scientific Affairs, Global Developed Markets, Dr. Reddy's Laboratories, discusses new initiatives at the company. / read more /
The Reality of Continuous Pharmaceutical Manufacturing
Taking place on 26–28 March 2019, GEA, Siemens and Perceptive Engineering will host an inaugural 3-day conference to examine the fact and fiction of Continuous Manufacturing (CM) in the pharmaceutical industry. / Read more/
VAI's Cart2Core®, a patent pending technology, virtually eliminates the problematic issue of correct aseptic cart transference by making the cart top transferable to a new base at each new classification. / Read more/
Date: 25 – 27 March 2019 Venue: Messe Wien Exhibition & Congress Center, Vienna, Austria
The thirteenth annual BIO-Europe Spring® conference is the premier springtime partnering conference for the biotechnology industry. For its 2019 edition, BIO-Europe Spring comes to Vienna, Austria on March 25–27, 2019. / Read more/
The editors explore new tools for bio/pharma lab studies—such as robotics, augmented reality, and advanced instrumentation—as well as best practices for method development, multiple attribute monitoring, lab mixers, and raw material testing.
